Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Harvard

Randerath, W, Verbraecken, J, Andreas, S, Arzt, M, Bloch, KE, Brack, T, Buyse, B, De Backer, W, Eckert, DJ, Grote, L, Hagmeyer, L, Hedner, J, Jennum, P, La Rovere, MT, Miltz, C, McNicholas, WT, Montserrat, J, Naughton, M, Pepin, J-L, Pevernagie, D, Sanner, B, Testelmans, D, Tonia, T, Vrijsen, B, Wijkstra, P & Levy, P 2017, 'Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep', European Respiratory Journal, bind 49, nr. 1, s. 1600959. https://doi.org/10.1183/13993003.00959-2016

APA

Randerath, W., Verbraecken, J., Andreas, S., Arzt, M., Bloch, K. E., Brack, T., Buyse, B., De Backer, W., Eckert, D. J., Grote, L., Hagmeyer, L., Hedner, J., Jennum, P., La Rovere, M. T., Miltz, C., McNicholas, W. T., Montserrat, J., Naughton, M., Pepin, J-L., ... Levy, P. (2017). Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep. European Respiratory Journal, 49(1), 1600959. https://doi.org/10.1183/13993003.00959-2016

CBE

Randerath W, Verbraecken J, Andreas S, Arzt M, Bloch KE, Brack T, Buyse B, De Backer W, Eckert DJ, Grote L, Hagmeyer L, Hedner J, Jennum P, La Rovere MT, Miltz C, McNicholas WT, Montserrat J, Naughton M, Pepin J-L, Pevernagie D, Sanner B, Testelmans D, Tonia T, Vrijsen B, Wijkstra P, Levy P. 2017. Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep. European Respiratory Journal. 49(1):1600959. https://doi.org/10.1183/13993003.00959-2016

MLA

Vancouver

Author

Randerath, Winfried ; Verbraecken, Johan ; Andreas, Stefan ; Arzt, Michael ; Bloch, Konrad E ; Brack, Thomas ; Buyse, Bertien ; De Backer, Wilfried ; Eckert, Danny Joel ; Grote, Ludger ; Hagmeyer, Lars ; Hedner, Jan ; Jennum, Poul ; La Rovere, Maria Teresa ; Miltz, Carla ; McNicholas, Walter T ; Montserrat, Josep ; Naughton, Matthew ; Pepin, Jean-Louis ; Pevernagie, Dirk ; Sanner, Bernd ; Testelmans, Dries ; Tonia, Thomy ; Vrijsen, Bart ; Wijkstra, Peter ; Levy, Patrick. / Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep. I: European Respiratory Journal. 2017 ; Bind 49, Nr. 1. s. 1600959.

Bibtex

@article{fa3cb4c8b6c445269c9d3e700d3a89ec,
title = "Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep",
abstract = "The complexity of central breathing disturbances during sleep has become increasingly obvious. They present as central sleep apnoeas (CSAs) and hypopnoeas, periodic breathing with apnoeas, or irregular breathing in patients with cardiovascular, other internal or neurological disorders, and can emerge under positive airway pressure treatment or opioid use, or at high altitude. As yet, there is insufficient knowledge on the clinical features, pathophysiological background and consecutive algorithms for stepped-care treatment. Most recently, it has been discussed intensively if CSA in heart failure is a {"}marker{"} of disease severity or a {"}mediator{"} of disease progression, and if and which type of positive airway pressure therapy is indicated. In addition, disturbances of respiratory drive or the translation of central impulses may result in hypoventilation, associated with cerebral or neuromuscular diseases, or severe diseases of lung or thorax. These statements report the results of an European Respiratory Society Task Force addressing actual diagnostic and therapeutic standards. The statements are based on a systematic review of the literature and a systematic two-step decision process. Although the Task Force does not make recommendations, it describes its current practice of treatment of CSA in heart failure and hypoventilation.",
author = "Winfried Randerath and Johan Verbraecken and Stefan Andreas and Michael Arzt and Bloch, {Konrad E} and Thomas Brack and Bertien Buyse and {De Backer}, Wilfried and Eckert, {Danny Joel} and Ludger Grote and Lars Hagmeyer and Jan Hedner and Poul Jennum and {La Rovere}, {Maria Teresa} and Carla Miltz and McNicholas, {Walter T} and Josep Montserrat and Matthew Naughton and Jean-Louis Pepin and Dirk Pevernagie and Bernd Sanner and Dries Testelmans and Thomy Tonia and Bart Vrijsen and Peter Wijkstra and Patrick Levy",
note = "Copyright {\textcopyright}ERS 2016.",
year = "2017",
doi = "10.1183/13993003.00959-2016",
language = "English",
volume = "49",
pages = "1600959",
journal = "European Respiratory Journal",
issn = "0903-1936",
publisher = "European Respiratory Society",
number = "1",

}

RIS

TY - JOUR

T1 - Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep

AU - Randerath, Winfried

AU - Verbraecken, Johan

AU - Andreas, Stefan

AU - Arzt, Michael

AU - Bloch, Konrad E

AU - Brack, Thomas

AU - Buyse, Bertien

AU - De Backer, Wilfried

AU - Eckert, Danny Joel

AU - Grote, Ludger

AU - Hagmeyer, Lars

AU - Hedner, Jan

AU - Jennum, Poul

AU - La Rovere, Maria Teresa

AU - Miltz, Carla

AU - McNicholas, Walter T

AU - Montserrat, Josep

AU - Naughton, Matthew

AU - Pepin, Jean-Louis

AU - Pevernagie, Dirk

AU - Sanner, Bernd

AU - Testelmans, Dries

AU - Tonia, Thomy

AU - Vrijsen, Bart

AU - Wijkstra, Peter

AU - Levy, Patrick

N1 - Copyright ©ERS 2016.

PY - 2017

Y1 - 2017

N2 - The complexity of central breathing disturbances during sleep has become increasingly obvious. They present as central sleep apnoeas (CSAs) and hypopnoeas, periodic breathing with apnoeas, or irregular breathing in patients with cardiovascular, other internal or neurological disorders, and can emerge under positive airway pressure treatment or opioid use, or at high altitude. As yet, there is insufficient knowledge on the clinical features, pathophysiological background and consecutive algorithms for stepped-care treatment. Most recently, it has been discussed intensively if CSA in heart failure is a "marker" of disease severity or a "mediator" of disease progression, and if and which type of positive airway pressure therapy is indicated. In addition, disturbances of respiratory drive or the translation of central impulses may result in hypoventilation, associated with cerebral or neuromuscular diseases, or severe diseases of lung or thorax. These statements report the results of an European Respiratory Society Task Force addressing actual diagnostic and therapeutic standards. The statements are based on a systematic review of the literature and a systematic two-step decision process. Although the Task Force does not make recommendations, it describes its current practice of treatment of CSA in heart failure and hypoventilation.

AB - The complexity of central breathing disturbances during sleep has become increasingly obvious. They present as central sleep apnoeas (CSAs) and hypopnoeas, periodic breathing with apnoeas, or irregular breathing in patients with cardiovascular, other internal or neurological disorders, and can emerge under positive airway pressure treatment or opioid use, or at high altitude. As yet, there is insufficient knowledge on the clinical features, pathophysiological background and consecutive algorithms for stepped-care treatment. Most recently, it has been discussed intensively if CSA in heart failure is a "marker" of disease severity or a "mediator" of disease progression, and if and which type of positive airway pressure therapy is indicated. In addition, disturbances of respiratory drive or the translation of central impulses may result in hypoventilation, associated with cerebral or neuromuscular diseases, or severe diseases of lung or thorax. These statements report the results of an European Respiratory Society Task Force addressing actual diagnostic and therapeutic standards. The statements are based on a systematic review of the literature and a systematic two-step decision process. Although the Task Force does not make recommendations, it describes its current practice of treatment of CSA in heart failure and hypoventilation.

U2 - 10.1183/13993003.00959-2016

DO - 10.1183/13993003.00959-2016

M3 - Journal article

C2 - 27920092

VL - 49

SP - 1600959

JO - European Respiratory Journal

JF - European Respiratory Journal

SN - 0903-1936

IS - 1

ER -

ID: 49649614